SYNOVUS FINANCIAL CORP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$77,000
-39.8%
629
-57.5%
0.00%
-50.0%
Q1 2020$128,000
-23.8%
1,480
-7.7%
0.00%0.0%
Q4 2019$168,000
-4.5%
1,604
+4.5%
0.00%
-33.3%
Q3 2019$176,000
-21.8%
1,535
+17.6%
0.00%0.0%
Q2 2019$225,000
+2.3%
1,3050.0%0.00%
-25.0%
Q1 2019$220,000
+193.3%
1,305
+69.5%
0.00%
+300.0%
Q4 2018$75,000
-40.9%
770
+4.8%
0.00%
-50.0%
Q3 2018$127,000
+122.8%
735
+79.3%
0.00%
+100.0%
Q2 2018$57,0004100.00%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders